Experienced in Intersex

Min Long

Chongqing, CN 
Experienced in Intersex
Chongqing, CN 
OverviewLocationsClinical Research

Overview

Min Long practices in Chongqing, China. Long is rated as an Experienced expert by MediFind in the treatment of Intersex. Their top areas of expertise are Empty Sella Syndrome, Hypogonadism Primary Partial Alopecia, Polycystic Ovary Syndrome, and Ovarian Cysts.

Their clinical research consists of co-authoring 43 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Intersex.

Locations

Chongqing, 400038, China
Other Locations
Xinqiao, 400037, China
Baise City, 533000, China
Guangxi Key Lab Of Processing For Nonferrous Metals And Featured Materials And Key Lab Of New Processing Technology For Nonferrous Metals And Materials, Nanning, 530004, China
Tanjiagang, 400038, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Randomized Clinical Trial to Evaluate The Effect of Metformin-GLP-1 Receptor Agonist Versus Oral Contraceptive (OC) Therapy on Reproductive Disorders and Cardiovascular Risks in Overweight Polycystic Ovarian Syndrome (PCOS) Patients
Randomized Clinical Trial to Evaluate The Effect of Metformin-GLP-1 Receptor Agonist Versus Oral Contraceptive (OC) Therapy on Reproductive Disorders and Cardiovascular Risks in Overweight Polycystic Ovarian Syndrome (PCOS) Patients
Enrollment Status: Completed
Publish Date: December 04, 2023
Intervention Type: Drug
Study Drugs: Metformin-GLP-1 Receptor Agonist, Metformin-Oral Contraceptive(OC)
Study Phase: Phase 4

43 Total Publications

Efficient production of medium-chain fatty acids in engineered Escherichia coli strains from ionic liquids Pre-treated bamboo enzymatic hydrolysate with carbon dioxide fixation.
Efficient production of medium-chain fatty acids in engineered Escherichia coli strains from ionic liquids Pre-treated bamboo enzymatic hydrolysate with carbon dioxide fixation.
Journal: Bioresource technology
Published: August 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Long's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile